کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
15638 | 42462 | 2014 | 6 صفحه PDF | دانلود رایگان |
• Prediction of Type 2 diabetes allows intervention which slows disease progression.
• Genetic and metabolomic approaches have had limited success in diabetes prediction.
• Hypothesis-based hyperbolic law of glucose tolerance (DI) predicts Type 2 diabetes.
• It is important to easily measure DI in a nonclinical setting.
• This may be possible by merging hypothesis-generating and hypothesis-driven approaches.
Prevalence of Type 2 diabetes has increased at an alarming rate, highlighting the need to correctly predict the development of this disease in order to allow intervention and thus, slow progression of the disease and resulting metabolic derangement. There have been many recent ‘advances’ geared toward the detection of pre-diabetes, including genome wide association studies and metabolomics. Although these approaches generate a large amount of data with a single blood sample, studies have indicated limited success using genetic and metabolomics information alone for identification of disease risk. Clinical assessment of the disposition index (DI), based on the hyperbolic law of glucose tolerance, is a powerful predictor of Type 2 diabetes, but is not easily assessed in the clinical setting. Thus, it is evident that combining genetic or metabolomic approaches for a more simple assessment of DI may provide a useful tool to identify those at highest risk for Type 2 diabetes, allowing for intervention and prevention.
Figure optionsDownload high-quality image (159 K)Download as PowerPoint slide
Journal: Current Opinion in Biotechnology - Volume 28, August 2014, Pages 165–170